Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
85.70B | 83.85B | 80.26B | 85.75B | 72.30B | 55.95B | Gross Profit |
33.08B | 31.87B | 27.71B | 27.15B | 24.69B | 19.22B | EBIT |
19.77B | 18.83B | 14.99B | 15.05B | 13.95B | 9.49B | EBITDA |
22.85B | 22.40B | 17.81B | 17.59B | 16.00B | 12.00B | Net Income Common Stockholders |
14.59B | 14.08B | 10.92B | 10.55B | 9.68B | 7.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
43.69B | 52.15B | 38.22B | 32.66B | 31.10B | 30.59B | Total Assets |
121.98B | 130.59B | 118.17B | 107.27B | 101.19B | 85.11B | Total Debt |
1.27B | 1.23B | 1.32B | 1.14B | 1.12B | 834.37M | Net Debt |
-42.42B | -50.92B | -36.89B | -31.48B | -29.94B | -29.71B | Total Liabilities |
21.64B | 24.47B | 25.46B | 22.90B | 22.48B | 15.63B | Stockholders Equity |
100.34B | 106.12B | 92.71B | 84.36B | 78.71B | 69.47B |
Cash Flow | Free Cash Flow | ||||
0.00 | 17.00B | 10.13B | 7.37B | 4.70B | 7.33B | Operating Cash Flow |
0.00 | 19.20B | 12.44B | 13.46B | 7.42B | 8.68B | Investing Cash Flow |
0.00 | -3.59B | -1.12B | -6.71B | -4.69B | -3.91B | Financing Cash Flow |
0.00 | -3.53B | -6.27B | -7.55B | -3.79B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥146.44B | 11.10 | 4.02% | 5.75% | -1.75% | ||
76 Outperform | ¥133.79B | 9.84 | 13.95% | 3.26% | 4.47% | 29.40% | |
76 Outperform | ¥38.55B | 16.23 | 4.54% | 13.35% | 36.30% | ||
75 Outperform | ¥28.19B | 12.55 | 3.02% | 5.18% | 30.93% | ||
73 Outperform | ¥32.64B | 3.48 | 4.25% | 0.79% | 104.91% | ||
71 Outperform | ¥72.54B | 9.17 | 0.90% | 2.19% | 11.00% | ||
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% |